Cargando…
Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
BACKGROUND: 3’-Deoxy-3’-[(18)F]fluorothymidine ([(18)F]FLT) PET has limited utility in abdominal imaging due to high physiological hepatic uptake of a tracer. We evaluated [(18)F]FLT-PET/CT combined with a temporal-intensity information-based voxel-clustering approach termed kinetic spatial filterin...
Autores principales: | Sharma, R., Mapelli, P., Hanna, G. B., Goldin, R., Power, D., Al-Nahhas, A., Merchant, S., Ramaswami, R., Challapalli, A., Barwick, T., Aboagye, E. O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112222/ https://www.ncbi.nlm.nih.gov/pubmed/27854031 http://dx.doi.org/10.1186/s13550-016-0234-3 |
Ejemplares similares
-
Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021) -
Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019) -
Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET
por: Sharma, Rohini, et al.
Publicado: (2020) -
The Positron Emission Tomography Tracer 3’-Deoxy-3’-[(18)F]Fluorothymidine ([(18)F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice
por: Wiehr, Stefan, et al.
Publicado: (2016) -
A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show (18)F-Fluorothymidine “Flare” on Positron Emission Tomography
por: Aravind, Preetha, et al.
Publicado: (2023)